BioCorRx (BICX) Short term Debt (2015 - 2024)

BioCorRx's Short term Debt history runs 8 years deep, the most recent figure standing at $1.2 million for Q3 2024.

• In Q3 2024, Short term Debt changed N/A year-over-year to $1.2 million; the TTM figure through Sep 2024 stood at $1.2 million (changed N/A YoY), while the FY2023 annual figure was $999088.0, changed N/A from the prior year.
• Short term Debt came in at $1.2 million for Q3 2024 at BioCorRx, up from $865353.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $3.1 million in Q2 2022 to a low of $31580.0 in Q4 2021.
• A 5-year average of $1.8 million and a median of $2.3 million in 2020 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt gained 25.17% in 2020 and plunged 98.68% in 2021, its largest moves.
• BioCorRx's Short term Debt stood at $2.4 million in 2020, then slumped by 98.68% to $31580.0 in 2021, then jumped by 9721.92% to $3.1 million in 2022, then plunged by 67.79% to $999088.0 in 2023, then advanced by 21.61% to $1.2 million in 2024.
• According to Business Quant data, Short term Debt over the past three periods registered $1.2 million, $865353.0, and $80190.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.

Peer Comparison